| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 13 | 2017 | 442 | 1.700 |
Why?
|
| Colitis | 10 | 2018 | 156 | 0.960 |
Why?
|
| Myocardium | 12 | 2017 | 1204 | 0.770 |
Why?
|
| Tissue Engineering | 5 | 2021 | 212 | 0.680 |
Why?
|
| Cell Differentiation | 5 | 2017 | 1034 | 0.640 |
Why?
|
| Microscopy, Confocal | 9 | 2014 | 337 | 0.560 |
Why?
|
| Protein Kinase C | 2 | 2007 | 270 | 0.490 |
Why?
|
| Databases as Topic | 1 | 2014 | 49 | 0.480 |
Why?
|
| Peer Review, Research | 1 | 2014 | 21 | 0.480 |
Why?
|
| Bacillus anthracis | 2 | 2004 | 11 | 0.470 |
Why?
|
| Information Dissemination | 1 | 2014 | 113 | 0.440 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2018 | 59 | 0.430 |
Why?
|
| Macrophages | 7 | 2022 | 647 | 0.390 |
Why?
|
| T-Lymphocytes, Regulatory | 5 | 2018 | 199 | 0.350 |
Why?
|
| Heart | 7 | 2007 | 850 | 0.350 |
Why?
|
| Microscopy | 2 | 2012 | 64 | 0.350 |
Why?
|
| Animals | 39 | 2022 | 20881 | 0.350 |
Why?
|
| Glioma | 3 | 2015 | 140 | 0.340 |
Why?
|
| Interleukin-10 | 4 | 2015 | 144 | 0.330 |
Why?
|
| Mice | 25 | 2022 | 8474 | 0.320 |
Why?
|
| Myofibrils | 2 | 2005 | 35 | 0.310 |
Why?
|
| Bacillus subtilis | 2 | 2004 | 49 | 0.290 |
Why?
|
| Intestinal Mucosa | 6 | 2018 | 219 | 0.290 |
Why?
|
| Cytokines | 6 | 2018 | 866 | 0.280 |
Why?
|
| Stilbenes | 3 | 2012 | 57 | 0.280 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 158 | 0.270 |
Why?
|
| Isoenzymes | 1 | 2007 | 308 | 0.260 |
Why?
|
| Extracellular Matrix | 5 | 2010 | 493 | 0.250 |
Why?
|
| Muscle, Skeletal | 3 | 2022 | 396 | 0.250 |
Why?
|
| Cell Size | 1 | 2005 | 76 | 0.250 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2018 | 234 | 0.250 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2018 | 46 | 0.250 |
Why?
|
| Ruthenium Red | 1 | 2004 | 5 | 0.240 |
Why?
|
| Indicators and Reagents | 1 | 2004 | 63 | 0.240 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2003 | 31 | 0.220 |
Why?
|
| MicroRNAs | 2 | 2021 | 447 | 0.220 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 45 | 0.220 |
Why?
|
| Biocompatible Materials | 2 | 2021 | 247 | 0.220 |
Why?
|
| Leptin | 2 | 2013 | 80 | 0.210 |
Why?
|
| Fluorouracil | 1 | 2022 | 130 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 627 | 0.200 |
Why?
|
| Glycoproteins | 1 | 2003 | 238 | 0.200 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 370 | 0.200 |
Why?
|
| Dextran Sulfate | 5 | 2016 | 88 | 0.200 |
Why?
|
| Monocytes | 1 | 2022 | 210 | 0.190 |
Why?
|
| Lymphocytes | 2 | 2021 | 228 | 0.190 |
Why?
|
| Immunomodulation | 1 | 2021 | 35 | 0.190 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 371 | 0.190 |
Why?
|
| Receptor, Angiotensin, Type 2 | 3 | 2008 | 31 | 0.190 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 245 | 0.190 |
Why?
|
| Muscular Diseases | 1 | 2021 | 41 | 0.190 |
Why?
|
| Rats | 12 | 2008 | 5300 | 0.190 |
Why?
|
| Connexin 43 | 3 | 2015 | 62 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 2791 | 0.190 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 37 | 0.180 |
Why?
|
| Adipocytes | 1 | 2021 | 88 | 0.180 |
Why?
|
| Regeneration | 1 | 2021 | 105 | 0.180 |
Why?
|
| Phytotherapy | 2 | 2012 | 53 | 0.180 |
Why?
|
| T-Lymphocytes | 3 | 2016 | 597 | 0.170 |
Why?
|
| Genistein | 1 | 2018 | 26 | 0.160 |
Why?
|
| Intestines | 2 | 2011 | 114 | 0.160 |
Why?
|
| Macrophage Activation | 1 | 2018 | 75 | 0.160 |
Why?
|
| Microscopy, Electron | 5 | 2004 | 351 | 0.150 |
Why?
|
| Heart Defects, Congenital | 1 | 2003 | 596 | 0.150 |
Why?
|
| Interleukins | 1 | 2018 | 79 | 0.150 |
Why?
|
| Thiazoles | 1 | 2018 | 95 | 0.150 |
Why?
|
| Indoles | 1 | 2018 | 146 | 0.140 |
Why?
|
| RNA, Messenger | 4 | 2016 | 1664 | 0.140 |
Why?
|
| Cell Culture Techniques | 3 | 2008 | 189 | 0.140 |
Why?
|
| Heart Valves | 2 | 2010 | 171 | 0.140 |
Why?
|
| Animals, Newborn | 6 | 2008 | 396 | 0.140 |
Why?
|
| Th17 Cells | 2 | 2014 | 116 | 0.140 |
Why?
|
| Amidohydrolases | 1 | 2016 | 60 | 0.130 |
Why?
|
| Actins | 2 | 2015 | 249 | 0.130 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Interleukin-13 | 1 | 2015 | 16 | 0.130 |
Why?
|
| CD11b Antigen | 2 | 2014 | 47 | 0.130 |
Why?
|
| Chemokines | 1 | 2015 | 119 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 89 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 786 | 0.120 |
Why?
|
| Receptors, CXCR3 | 2 | 2011 | 16 | 0.120 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2014 | 9 | 0.120 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2015 | 140 | 0.120 |
Why?
|
| Interleukin-4 | 1 | 2014 | 69 | 0.120 |
Why?
|
| Cytomegalovirus | 1 | 2015 | 63 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2015 | 69 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2014 | 101 | 0.120 |
Why?
|
| Spores, Bacterial | 2 | 2004 | 17 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 3 | 2009 | 160 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 244 | 0.120 |
Why?
|
| Cystitis | 1 | 2013 | 18 | 0.120 |
Why?
|
| Cystitis, Interstitial | 1 | 2013 | 12 | 0.120 |
Why?
|
| Chemokine CXCL10 | 1 | 2013 | 21 | 0.120 |
Why?
|
| Obesity | 1 | 2021 | 1076 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 94 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 239 | 0.110 |
Why?
|
| Fibroblasts | 3 | 2008 | 902 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 659 | 0.110 |
Why?
|
| Antibodies | 1 | 2013 | 241 | 0.110 |
Why?
|
| Adenoma | 2 | 2011 | 132 | 0.110 |
Why?
|
| Venules | 1 | 2012 | 8 | 0.100 |
Why?
|
| Female | 17 | 2018 | 38074 | 0.100 |
Why?
|
| Rutin | 1 | 2012 | 4 | 0.100 |
Why?
|
| Arterioles | 1 | 2012 | 40 | 0.100 |
Why?
|
| Cell Adhesion | 4 | 2008 | 324 | 0.100 |
Why?
|
| Enterotoxins | 1 | 2012 | 40 | 0.100 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 35 | 0.100 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2011 | 27 | 0.100 |
Why?
|
| Capillaries | 1 | 2012 | 105 | 0.100 |
Why?
|
| Complementary Therapies | 1 | 2012 | 43 | 0.100 |
Why?
|
| Receptors, Chemokine | 1 | 2011 | 26 | 0.100 |
Why?
|
| Hematopoietic System | 1 | 2011 | 8 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2014 | 1692 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2011 | 30 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 742 | 0.100 |
Why?
|
| Interleukin-17 | 1 | 2011 | 62 | 0.090 |
Why?
|
| Cannabinoids | 1 | 2011 | 90 | 0.090 |
Why?
|
| Myeloid Cells | 1 | 2011 | 57 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 226 | 0.090 |
Why?
|
| Humans | 12 | 2021 | 68618 | 0.090 |
Why?
|
| Collagen | 4 | 2008 | 636 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 163 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 144 | 0.090 |
Why?
|
| Chickens | 1 | 2010 | 232 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2011 | 2673 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 213 | 0.090 |
Why?
|
| Connexins | 2 | 2006 | 35 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2009 | 47 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 1293 | 0.080 |
Why?
|
| Gap Junctions | 2 | 2015 | 29 | 0.080 |
Why?
|
| Tristetraprolin | 1 | 2009 | 9 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2009 | 71 | 0.080 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2008 | 2 | 0.080 |
Why?
|
| Kartagener Syndrome | 1 | 2008 | 3 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 328 | 0.080 |
Why?
|
| Heart Ventricles | 4 | 2015 | 738 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 626 | 0.080 |
Why?
|
| Blastocyst | 1 | 2008 | 17 | 0.080 |
Why?
|
| Editorial Policies | 1 | 2009 | 32 | 0.080 |
Why?
|
| Twins | 1 | 2008 | 42 | 0.080 |
Why?
|
| Mice, Transgenic | 5 | 2015 | 1033 | 0.080 |
Why?
|
| Flow Cytometry | 4 | 2011 | 489 | 0.080 |
Why?
|
| Spermatozoa | 1 | 2008 | 75 | 0.080 |
Why?
|
| Receptors, Mitogen | 2 | 2005 | 23 | 0.080 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2007 | 12 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2005 | 100 | 0.080 |
Why?
|
| Colon | 3 | 2016 | 168 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 2550 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2009 | 432 | 0.070 |
Why?
|
| Cell Communication | 1 | 2008 | 116 | 0.070 |
Why?
|
| Adult | 6 | 2015 | 21403 | 0.070 |
Why?
|
| Lung | 1 | 2012 | 849 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2008 | 122 | 0.070 |
Why?
|
| Protein Kinase C-delta | 1 | 2007 | 12 | 0.070 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2007 | 28 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2007 | 24 | 0.070 |
Why?
|
| Body Weight | 3 | 2014 | 554 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 215 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2008 | 213 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2018 | 110 | 0.070 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2006 | 26 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 208 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 299 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2007 | 1200 | 0.070 |
Why?
|
| Cell Separation | 4 | 2011 | 132 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2006 | 108 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 333 | 0.070 |
Why?
|
| Antioxidants | 1 | 2008 | 304 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 507 | 0.060 |
Why?
|
| Apoptosis | 2 | 2011 | 1641 | 0.060 |
Why?
|
| Iraq | 2 | 2015 | 24 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 756 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2004 | 21 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 249 | 0.060 |
Why?
|
| Phenotype | 2 | 2018 | 947 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2003 | 2083 | 0.060 |
Why?
|
| Uronic Acids | 1 | 2003 | 1 | 0.060 |
Why?
|
| Bacillus cereus | 1 | 2003 | 3 | 0.060 |
Why?
|
| Teichoic Acids | 1 | 2003 | 7 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2008 | 954 | 0.060 |
Why?
|
| Bioterrorism | 1 | 2003 | 12 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2021 | 2689 | 0.060 |
Why?
|
| Carbohydrates | 1 | 2003 | 57 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 25 | 0.060 |
Why?
|
| Sarcomeres | 1 | 2003 | 32 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2003 | 30 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2003 | 17 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 20 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2013 | 1330 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 2004 | 383 | 0.050 |
Why?
|
| Integrin beta1 | 1 | 2003 | 48 | 0.050 |
Why?
|
| Neutrophils | 2 | 2015 | 204 | 0.050 |
Why?
|
| Genotype | 2 | 2015 | 786 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 106 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2008 | 1451 | 0.050 |
Why?
|
| Weight Loss | 2 | 2016 | 319 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 58 | 0.050 |
Why?
|
| Aging | 1 | 2007 | 911 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2014 | 53 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1851 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 981 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2002 | 202 | 0.050 |
Why?
|
| Mucous Membrane | 2 | 2011 | 66 | 0.050 |
Why?
|
| Tissue Scaffolds | 1 | 2021 | 111 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2013 | 447 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 261 | 0.040 |
Why?
|
| Male | 7 | 2015 | 37321 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 615 | 0.040 |
Why?
|
| Hypertension | 1 | 2008 | 1535 | 0.040 |
Why?
|
| Disease Progression | 2 | 2011 | 1038 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 126 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 3187 | 0.040 |
Why?
|
| Chick Embryo | 2 | 2010 | 379 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2002 | 617 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2018 | 118 | 0.040 |
Why?
|
| Middle Aged | 4 | 2015 | 21147 | 0.040 |
Why?
|
| Ligands | 1 | 2018 | 317 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 710 | 0.030 |
Why?
|
| Pregnancy | 3 | 2008 | 2334 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2015 | 41 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 1174 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2015 | 38 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 69 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 53 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 90 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2015 | 85 | 0.030 |
Why?
|
| Discoidin Domain Receptors | 2 | 2005 | 16 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 97 | 0.030 |
Why?
|
| Aged | 3 | 2015 | 14862 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2014 | 18 | 0.030 |
Why?
|
| Collagen Type I | 2 | 2007 | 175 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 618 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 74 | 0.030 |
Why?
|
| Heart Failure | 1 | 2003 | 1180 | 0.030 |
Why?
|
| Chemokine CXCL11 | 1 | 2013 | 3 | 0.030 |
Why?
|
| Chemokine CXCL9 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Child | 2 | 2015 | 6405 | 0.030 |
Why?
|
| Apyrase | 1 | 2013 | 10 | 0.030 |
Why?
|
| Smad7 Protein | 1 | 2013 | 11 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 5717 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2013 | 35 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 80 | 0.030 |
Why?
|
| Time Factors | 3 | 2007 | 4655 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 63 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 86 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2013 | 241 | 0.030 |
Why?
|
| Ventricular Function, Left | 2 | 2008 | 481 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2013 | 230 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 149 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2012 | 149 | 0.030 |
Why?
|
| Plants | 1 | 2012 | 26 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 160 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 117 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 8912 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 186 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1553 | 0.020 |
Why?
|
| CpG Islands | 1 | 2011 | 51 | 0.020 |
Why?
|
| Serum Amyloid A Protein | 1 | 2011 | 33 | 0.020 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2011 | 38 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 94 | 0.020 |
Why?
|
| Osteopontin | 1 | 2011 | 28 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 329 | 0.020 |
Why?
|
| Feces | 1 | 2011 | 88 | 0.020 |
Why?
|
| Mast Cells | 1 | 2011 | 113 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2011 | 79 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2006 | 689 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 144 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 127 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 200 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 301 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 384 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 149 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 186 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1603 | 0.020 |
Why?
|
| Mesentery | 1 | 2009 | 17 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 619 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2011 | 193 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2009 | 98 | 0.020 |
Why?
|
| ELAV-Like Protein 1 | 1 | 2009 | 18 | 0.020 |
Why?
|
| ELAV Proteins | 1 | 2009 | 17 | 0.020 |
Why?
|
| Flagella | 1 | 2008 | 2 | 0.020 |
Why?
|
| Semen Analysis | 1 | 2008 | 5 | 0.020 |
Why?
|
| Embryo Culture Techniques | 1 | 2008 | 2 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2008 | 18 | 0.020 |
Why?
|
| Dyneins | 1 | 2008 | 10 | 0.020 |
Why?
|
| Sperm Motility | 1 | 2008 | 41 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 481 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 411 | 0.020 |
Why?
|
| Ginkgo biloba | 1 | 2008 | 4 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2009 | 155 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 474 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2009 | 237 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2009 | 258 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 2891 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 196 | 0.020 |
Why?
|
| Phalloidine | 1 | 2007 | 5 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 10 | 0.020 |
Why?
|
| Trypan Blue | 1 | 2007 | 24 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 282 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2007 | 13 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2008 | 54 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2007 | 20 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 189 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 848 | 0.020 |
Why?
|
| Gels | 1 | 2007 | 55 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 201 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 95 | 0.020 |
Why?
|
| Isometric Contraction | 1 | 2007 | 33 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 2007 | 33 | 0.020 |
Why?
|
| Culture Media | 1 | 2007 | 155 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2008 | 101 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2007 | 234 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 248 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 782 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2006 | 44 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1174 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2007 | 210 | 0.020 |
Why?
|
| Fetus | 1 | 2007 | 157 | 0.020 |
Why?
|
| Genes, APC | 1 | 2006 | 15 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 191 | 0.020 |
Why?
|
| Testis | 1 | 2006 | 37 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 43 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 341 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 166 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 714 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 475 | 0.020 |
Why?
|
| Ovary | 1 | 2006 | 99 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 317 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 371 | 0.020 |
Why?
|
| Models, Animal | 1 | 2006 | 252 | 0.020 |
Why?
|
| Cell Movement | 1 | 2008 | 630 | 0.020 |
Why?
|
| Ammonium Chloride | 1 | 2004 | 4 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2004 | 23 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 901 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2004 | 40 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2004 | 25 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 134 | 0.020 |
Why?
|
| Isoproterenol | 1 | 2004 | 163 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2004 | 80 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 71 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 114 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 236 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2006 | 601 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 65 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 1851 | 0.010 |
Why?
|
| Myosin Light Chains | 1 | 2003 | 18 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 322 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2004 | 220 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 144 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 2003 | 37 | 0.010 |
Why?
|
| Ventricular Function | 1 | 2003 | 93 | 0.010 |
Why?
|
| Actin Cytoskeleton | 1 | 2003 | 37 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 76 | 0.010 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2003 | 59 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 27 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 532 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 88 | 0.010 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2002 | 25 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 541 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 1030 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 189 | 0.010 |
Why?
|
| Cadherins | 1 | 2002 | 93 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 246 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 770 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2077 | 0.010 |
Why?
|